TABLE 5.
Type | Model | Herbal formula | Inducer | Animal/cell | Major findings | References |
---|---|---|---|---|---|---|
In vivo | HUA and hyperlipidemia | Dendrobium officinalis Six Nostrum | PO and hihg-fat sorghum feed | SD rats | XOD, ADA, LPL, FABP1, HPRT1, NLRP3, Caspase-1, TLR4 | Guo et al. (2020) |
In vivo | Gouty arthritis | Simiao decoction | Yeast, MSU | Mice | NLRP3, ACS, caspase1, XOD, ADA, IL- 1α, IL-6, IL-1β, IL-9, IL-12, granulocyte colony stimulating factor; MCP-1, TNF-α, STAT3, APOB, caspase 8, c-FOS, PPARα, FN1, LPL, MIP-1α, MIP-1β | Lin et al. (2020) |
In vivo | Acute gouty arthritis with HUA | Tu-Teng-Cao | PO, MSU | SD rats | TNF-α, IL-6, IL-1β | Yao et al. (2020) |
In vivo | HUA | Erding granules | PO | Mice | N/A | Zuo et al. (2020) |
In vivo | HUA | TongFengTangSan | PO | SD rats | XOD | Chen et al. (2019b) |
In vivo | HUA | Alismatis Rhizoma and Rhizoma Smilacis Glabrae decotion | PO, adenine | SD rats | XOD, URAT1 | Cheng et al. (2019) |
In vivo | HUA | Er Miao wan | Fructose | SD rats | N/A | Huang et al. (2019a) |
In vivo | Renal stones | Huashi pill | Ethylene glycol, ammonium chloride, calcium gluconate | SD rats | Osteopontin | Yang et al. (2019a) |
In vivo | HUA | Modified Chuanhu anti-gout mixture | PO | Mice | XOD, URAT1 | You et al. (2019) |
In vivo | Acute gouty arthritis | Jia-Wei-Si-Miao-Wan | Monosodium urate | Rats | TLR4, NLRP3, ASC, caspase-1, NF-κB, IL-1β, IL-18 | Yuan et al. (2019) |
In vivo | HUA | Erding granule | PO | Mice, SD rats | GLUT9, OAT1, URAT1 | Zhang et al. (2019a) |
In vivo and in vitro | HUA and acute gouty arthritis | The Selaginella moellendorffii prescription | PO, adenine, MSU, LPS | Mice, rats, RAW264.7 cells | NO, NF-κB, NLRP3, IL-1β, PGE-2, IL-8 | Zhang et al. (2019b) |
In vivo | Acute gouty arthritis | Tongfengning capsule | MSU | Rats | TNF-α, IL-1β | Fan et al. (2018) |
In vivo | T2DM | Spleen-kidney supplementing formula | High-fat diet, low-dose streptozotocin | Wistar rats | TGF-β1, miR-21, PTEN | Tian et al. (2018) |
In vivo | HUA | Ermiaowan | Xanthine and oxonic acid potassium salt | Rats | N/A | Wei et al. (2018) |
In vivo | HUA | Compound tufuling granules | Rats | TNF-α, IL-1β | Wu et al. (2018a) | |
In vivo | HUA | ShiZhiFang | PO | SD rats | XOD, OAT1, OAT3 | Wu et al. (2018b) |
In vivo | HUA | Erding formula | Hypoxanthine and PO | Mice | URAT1, OAT3 | Zuo et al. (2018) |
In vivo | HUA | Qi-Zhu-Xie-Zhuo-Fang | Adenine and PO | Rats | XO, E-cadherin, α-SMA | Huijuan et al. (2017) |
In vivo | HUA | Shizhifang | PO | SD rats | TXNIP, NLRP3, ASC, caspase-1, IL-1β, IL-18, ROS | Wu et al. (2017) |
In vivo | HUA | Quzhuotongbi decoction | Yeast | SD rats | N/A | Chen et al. (2016a) |
In vivo | Gouty arthritis | Zisheng Shenqi decoction | MSU | Rats | IL-1β, TNF-α, IκB, NF-κB, NALP1, NALP6, ROS | Han et al. (2016) |
In vivo | HUA | RuPeng15 powder | PO | SD rats | XO | Kou et al. (2016) |
In vivo | Gouty arthritis | Xiaofeng granules | MSU | SD rats, rabbits | IL-1β, IL-6, TNF-α, iNOS, ADAMTS-4, TIMP-3 | Shi et al. (2016a) |
In vivo | HUA | Siwu decoction | PO | Mice | XO, URAT1, GLUT9, OAT1, ABCG2, OCT1, OCT2, OCTN1, OCTN2, NLRP3, ASC, caspase-1, IL-1β | Wang et al. (2016b) |
In vivo | HUA | Jianpi Huashi decoction | PO | Rats | XO | Wang et al. (2016d) |
In vivo and in vitro | Gout | Sanmiao formula | Animals: PO and cold bath, cells: MSU | SD rats, rabbits, primary chondrocyte | IL-1β, TNF-α, MMP-3, TIMP-1, ADAMTS-4, TIMP-3 | Zhu et al. (2016) |
In vivo | HUA | Karapxa decoction | Yeast and PO | Mice | XO | Amat et al. (2015) |
In vivo | HUA | Ermiao pill | PO | SD rats | XO | Chen et al. (2015b) |
In vivo | HUA | Si-Wu-Tang and Er-Miao-San | PO and adenine | SD rats | XO, OAT1, OAT3 | Guo et al. (2015) |
In vivo | HUA | Shuang-Qi gout capsule | PO | Mice | URAT1, OAT1, OCT1, OCT2, ABCG2, OCTN1, OCTN2, GLUT9 | Kodithuwakku et al. (2015) |
In vivo | Gouty arthritis | RuPeng15 powder | MSU | SD rats | NF-κB, TNF-α, IL-1β, IL-8 | Kou et al. (2015) |
In vivo | HUA | Compound tufuling granules | Yeast and PO | Mice | GLUT9 | Liu et al. (2015) |
In vivo | HUA and metabolic syndrome | Simiao pill | Fructose | SD rats | Nephrin, podocin, CD2AP, Sirt1, NF-κB, IL-1β, NLRP3, ACS, caspase1 | Ma et al. (2015) |
In vivo | HUA | Xie-Zhuo-Chu-Bi-Fang | Adenine and PO | Mice | URAT1, miR-34a | Sun et al. (2015) |
In vivo | HUA | Wuling san | Fructose | Mice | URAT1, GLUT9, ABCG2, OAT1, OCT1, OCT2 | Yang et al. (2015) |
In vivo | Urate nephropathy | Compound qingqin liquid | Adenine and PO | SD rats | TLR2, TLR4 | Chen et al. (2014c) |
In vivo | HUA | Modified Simiao wan | Oxonic acid potassium salt, hypoxanthine | SD rats | XOD | Pan et al. (2014) |
In vivo | HUA | Compound qingqin liquid | Adenine and PO | SD rats | COX-2 | Shang et al. (2014) |
In vivo | HUA | Jianpihuashi decoction | PO | SD rats | XO | Chen et al. (2013a) |
In vivo | HUA | Wuling san | PO | Mice | URAT1, GLUT9, OAT1, OCT1, OCT2, OCTN2 | Ding et al. (2013) |
In vivo and in vitro | Gout arthritis | Shuang-Qi gout capsule | MSU | Mice, SD rats, HUVECs | TNF-α, IL-1β | Kodithuwakku et al. (2013) |
In vivo | HUA | Tongfeng granule | Adenine and ethambutol | Rats | N/A | Liu et al. (2013) |
In vivo | HUA | Jieduxiezhuo decoction | Uric acid | Mice | N/A | Pan et al. (2013) |
In vivo and in vitro | MSU-induced inflammation | Modified Simiaowan | MSU | Mice, HUVECs | ICAM-1 | Shi et al. (2013) |
In vivo | HUA | Tongxi powder | Uric acid | Mice | N/A | Yang et al. (2013) |
In vivo | HUA | Modified Simiao decoction | PO | Mice | XO, URAT1, OAT1, SOD, MDA | Hua et al. (2012) |
In vivo | Acute gouty arthritis | Compound Shuiniujiao | MSU | SD rats | N/A | Cao et al. (2011) |
In vivo | HUA | Simiao pill | PO | Mice | URAT1, GLUT9, OAT1, OCT1, OCT2, OCTN1, OCTN2 | Hu et al. (2010) |
In vivo | HUA | Danggui Buxue Tang | Adenine, ethambutol | Rats | NO, NOS, SOD, MDA | Li et al. (2010) |
In vivo | HUA | Ermiao pill | Oxygen hydrochloride acid potassium salt | Mice | XOD, URAT1 | Lü et al. (2010) |
In vivo | HUA | Sanmiao wan | PO | Mice | XOD, URAT1 | Wang et al. (2010b) |
Abbreviations can be referred to Tables 3, 4. FABP1, fatty acid-binding protein; HPRT1, hypoxanthine-guanine phosphoribosyl transferase; APOB, apolipoprotein B; FOS, one subunit of activator protien-1; FN1, fibronectin1; MIP-1α, MIP-1 β, serum proinflammatory cytokines; TXNIP, thioredoxin interacting proteins; PTEN, phosphate and tension homology deleted on chromsome ten; NALP1/6, NACHT, LRR and PYD domains-containing protein one and six; ADAMTs, a family of metalloproteinases with thrombospondin motifs; TIMP, tissue inhibitor of metalloproteinase; CD2AP, CD2-associated protein.